How Most Clinics Source Their Biologics
Not all stem cell products are created equal. The difference between a diluted, replicated biologic and a full-concentration, ethically sourced product from a healthy local birth is the difference between marginal results and transformative outcomes. Understanding the supply chain behind the biologics you receive is not a technical detail — it is the most important question you can ask before choosing a regenerative medicine provider.
The vast majority of regenerative medicine clinics in the United States do not have direct relationships with their biologic sources. They purchase through distributors — intermediaries who aggregate products from multiple tissue banks, process them according to their own protocols, and resell them to clinics at a markup. By the time a vial reaches a patient, it may have changed hands three or four times.
Each handoff introduces risk. Dilution — intentional or accidental — reduces the concentration of viable cells. Temperature excursions during shipping degrade cell viability. Documentation gaps make it impossible to verify the health status of the donor, the conditions of procurement, or the integrity of the processing chain.
The Questions Every Patient Should Ask
When a clinic tells you their biologics are high quality, ask them to prove it. Ask for the certificate of analysis. Ask for the name of the tissue bank. Ask whether the product has been replicated — meaning whether the original cells were expanded in culture to produce a larger volume. Ask how many times the product changed hands between procurement and your treatment.
Most clinics cannot answer these questions. Not because they are being deceptive, but because they genuinely do not know. They trusted their distributor, who trusted their supplier, who may or may not have maintained rigorous standards throughout the chain.
The right questions to ask any regenerative medicine provider are: Who is your source? What is the chain of custody documentation? Has the product been diluted or replicated? What is the cell viability at the time of administration? Can you provide a certificate of analysis for the specific lot being used in my treatment?
The CellRX Standard
At CellRX, our Medical Director serves simultaneously as the Medical Director of our stem cell source company. This is not a marketing claim — it is a structural fact that changes everything about the quality and provenance of what we administer.
Because our Medical Director oversees both the clinic and the source company, every biologic we administer has been under direct physician oversight from the moment of ethical procurement through the moment it enters your body. There are no distributors. There are no intermediaries. There is no gap in the chain of custody.
Our biologics are sourced exclusively from healthy, consented local births. They are never diluted and never replicated — you receive the full therapeutic concentration of the original product. Every lot comes with complete documentation that we can provide upon request.
Why This Matters for Your Outcomes
The concentration and viability of the biologics you receive directly determines the magnitude of the regenerative response your body can mount. A diluted product with reduced cell viability will produce a diminished response — or no response at all. A full-concentration product from a verified, healthy source gives your body the maximum signal it needs to initiate repair.
This is why patients who have tried stem cell therapy elsewhere and seen minimal results often experience dramatically different outcomes at CellRX. The therapy is the same. The biology is the same. The difference is the quality of the product — and the integrity of the chain of custody behind it.